The BioInsights Podcast
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
Podcasting since 2022 • 56 episodes
The BioInsights Podcast
Latest Episodes
Exploring advances in bioconjugation: nanozymes, tissue tropism, and the future of responsive systems
Lauren Coyle (Commissioning Editor, Bioconjugation Insights) speaks to Vincent Rotello (Distinguished Professor of Chemistry, University of Massachusetts Amherst) about the advantages and limitations of different nanomate...
•
Season 4
•
Episode 6
•
15:29
The promise of antibody-oligonucleotide conjugates for neurological diseases
Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, speaks with Kerstin Hofer, Science and People Lead, Roche, about the evolving application of antibody-oligonucleotide conjugates in neurology. She highli...
•
Season 4
•
Episode 5
•
21:22
From innovation to access: bridging gaps in scalability and cold chain precision logistics for advanced therapies
Jokūbas Leikauskas, Editor, BioInsights, speaks to Rohin Iyer, Senior Director, Global Cell and Gene Therapy Operations, Marken, about addressing the complex logistics of cell and gene therapies through global infrastructure, prec...
•
Season 4
•
Episode 4
•
19:49
Enhancing mRNA results through strategic RNA design and quality control
In the last few years, mRNA has moved to the fore in the vaccine and cell and gene therapy fields, and as a result, its successful production for these downstream applications has never been more crucial. In this podcast episode, Róisin McGu...
•
Season 4
•
Episode 3
•
12:53
For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications
Roisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Stanley Crooke, Chairman, Founder and CEO, n-Lorem, about his long career and pioneering role in the antisense oligonucleotide (ASO) space, how RNA-t...
•
Season 4
•
Episode 2
•
19:09